Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-Funding Opportunity Announcement (FOA), PAR 16-098, Cooperative Research Agreements to the World Trade Center Health Program (U01); Amended Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— Funding Opportunity Announcement (FOA), PAR 16-098, Cooperative Research Agreements to the World Trade Center Health Program (U01); Dates and Times: March 27, 2019, 8:00 a.m.-5:00 p.m., EDT and March 28, 2019, 8:00 a.m.-12:00 p.m., EDT. Hampton Inn & Suites Atlanta Buckhead, 3312 Piedmont Road, Atlanta, Georgia 30305, which was published in the Federal Register on January 31, 2019, Volume 84, Number 21, pages 730.

The meeting is being amended to Atlanta Marriott Buckhead Hotel & Conference Center, 3405 Lenox Road NE, Atlanta, GA 30326, Telephone: (404) 261-9250. The meeting is closed to the public.

For Further Information Contact: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop L1055, Morgantown, West Virginia 26505, Telephone: (304) 285-5975, nxt2@cdc.gov.

The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Sherri Berger,

Chief Operating Officer, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2019-02164 Filed 2-12-19; 8:45 am]

BILLING CODE 4163-18-P